A Phase 2 interventional study of Medium Chain Triglyceride solution and Cannabis Sativa in OSTEOARTHRITIS OF THE KNEE, sponsored by Federal University of Latin American Integration. Completed at 1 site in Brazil. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-07-02.
Sponsored by Federal University of Latin American Integration · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 79 studies in Osteoarthritis, Knee with a site in Brazil — 12 open to participants now, 12 under way, 2 of them phase 3. Osteoarthritis, Knee · Brazil.
Among the 79 studies in Osteoarthritis, Knee with a site in Brazil, this one is the 55th largest by enrollment of the 77 interventional ones that give a count, is one of 7 that started in 2024, is one of 6 in phase 2, and was the 72nd registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →12 of the 79 studies in Osteoarthritis, Knee with a site in Brazil are open now. Recruiting first, the newest first:
University of Nove de Julho · Sites in Brazil
Ages 40–75
University of Nove de Julho · Sites in Brazil
Ages 40–80
University of Nove de Julho · Sites in Brazil
Ages 40–75
University of Nove de Julho · Sites in Brazil
Ages 40–80
University of Nove de Julho · Sites in Brazil
Ages 40–75
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 30 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
79 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 8 · Phase 3 10 · Phase 4 9
First in 2005; this study’s year is marked. 7 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 45 is below the median of 68 across 2,719 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 66 across the 77 interventional studies, 38 across the 2 observational. Of the 49 that completed or were terminated, 7 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 79 have an industry lead sponsor. The 10 most frequent:
Federal University of Latin American Integration is the lead sponsor of 6 studies on the registry; 1 is open to participants now.
Federal University of Latin American Integration has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
2 of the studies in Osteoarthritis, Knee with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06187038University of Nove de JulhoEffects of Including a Chronic Pain Neuroscience Education Program for Individuals With Knee OA | 2026-11-30 |
| NCT06905860Federal University of São PauloIntra-articular Infiltration of Platelet-Rich Fibrin vs Corticosteroid in Mild to Moderate Knee Osteoarthritis | 2027-06-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 79 studies in Osteoarthritis, Knee with a site in Brazil, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Osteoarthritis (OA) is the most prevalent joint disease in humans, often causing disability in affected individuals, especially the elderly. OA is characterized by mechanical joint pain, crepitus and short-term post-immobilization stiffness. OA pain has a variable pathophysiology and, despite the many pharmacological options available, its treatment is often ineffective and has significant side effects. The search for more effective and safer treatments is therefore essential in the field of OA. Among the possible treatments are substances derived from cannabis. Cannabis plants have been used for various purposes by humankind for thousands of years. Its best-known species, Cannabis sativa, has more than a hundred substances called cannabinoids or, more specifically, phytocannabinoids, the most important of which is cannabidiol (CBD). Although many pre-clinical studies indicate the usefulness of phytocannabinoids, clinical evidence for their application is currently scarce. Therefore, this project aims to investigate the effects of a CBD-rich extract of Cannabis sativa on the pain of patients with knee OA, as well as the possible adverse events of this treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
placebo (solution of Medium Chain Triglycerides, without any active ingredient)
Dietary Supplement: Medium Chain Triglyceride solution
Cannabis sativa extract with a CBD (45 mg/day)
Other: Cannabis Sativa
Placebo
Group 2: Cannabis sativa extract with CBD (45mg/day).
Pain levels
Change in pain levels, according to the score in the "pain" domain of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), using the Likert scale to assign a value to the answers obtained from the participants. The pain levels according to the score are 0-8 mild, greater than 8-14 moderate, greater than 14- 20 high.
Time frame: 2 months
Short Form Health Survey (SF-12)
Change in the Short Form Health Survey (SF-12) quality of life scores, according to the "maximal walking" and "activities of daily living" domains, where a score of 0 is the worst quality of life and 100 the best.
Time frame: 2 months
Depression
Changes in levels of depression using the Beck Depression scale. Changes in depression levels using the Beck depression scale. The disease level values range from 0-9 indicating that the individual is not depressed, 10-18 indicating mild to moderate depression, 19-29 indicating moderate to severe depression and 30-63 indicating severe depression.
Time frame: 2 months
Adverse events
presence of adverse events (AE) - proportion of patients with AE in the placebo and intervention groups;
Time frame: 2 months
Serious adverse events
presence of serious adverse events (AEs) - description of the serious AEs that may appear in each group.
Time frame: 2 months
Change in sleep quality
The Pittsburgh scale was used to see if there was any change in the participants' quality of sleep. The scale used classifies sleep quality as follows: * Good 0-4 * Bad -10 * Presence of sleep disturbance greater than 10
Time frame: 2 months
Renal Function Panel
Used as form to identify any renal impairment in pacientes that could result in any need of adjusting the dose or need to leave the study.
Time frame: 2 months
Visual Analogue Scale (VAS)
It is used in the healthcare field to measure the intensity of pain a person feels, usually on a scale from 0 to 10, where 0 means 'no pain' and 10 means 'the worst pain imaginable
Time frame: 2 month
Hepatic Panel
Used to monitor liver function in patients, as pacientes are receiving an oil-based medication that may overload the liver.
Time frame: 2 month
Plan to share: No
Ran from Jan 2024 to primary completion in Oct 2024, 9 months.
Of 43 non-industry phase 2 interventional studies under Osteoarthritis, Knee, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 61. This study's 9 months is below that.
Counting every sponsor, half of 101 studies reached it within 20 months; a quarter within 12 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Federal University of Latin American Integration